secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jade Biosciences, Inc. (JBIO)
CIK:        0001798749
Form:       8-K
Filed at:   2021-07-19T23:59:59+00:00
Accession:  0001104659-21-093268
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aerovate Therapeutics appoints Allison Dorval to Board of Directors
-------------------------------------------------------------------

- Allison Dorval, CFO of Voyager Therapeutics, appointed to Board effective July 15, 2021.
- Dorval appointed chair of Audit Committee; Joshua Resnick resigns from Audit Committee.
- Maha Katabi steps down as Audit Committee chair but remains a member; Dorval qualifies as independent and financial expert.
- Dorval to serve as Class II director until the 2023 annual meeting of stockholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1798749/000110465921093268/0001104659-21-093268-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1798749/000110465921093268/tm2122221d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-093268

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer